Cinctive Capital Management LP Acquires 43,669 Shares of Sabra Healthcare REIT, Inc. $SBRA

Cinctive Capital Management LP lifted its holdings in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 31.1% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 184,001 shares of the real estate investment trust’s stock after purchasing an additional 43,669 shares during the period. Cinctive Capital Management LP owned 0.07% of Sabra Healthcare REIT worth $3,430,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Founders Capital Management acquired a new position in Sabra Healthcare REIT during the third quarter worth $28,000. Covestor Ltd lifted its position in shares of Sabra Healthcare REIT by 23,720.0% in the third quarter. Covestor Ltd now owns 2,382 shares of the real estate investment trust’s stock worth $45,000 after buying an additional 2,372 shares during the last quarter. EverSource Wealth Advisors LLC boosted its stake in shares of Sabra Healthcare REIT by 150.7% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,555 shares of the real estate investment trust’s stock worth $47,000 after acquiring an additional 1,536 shares in the last quarter. Farther Finance Advisors LLC boosted its stake in shares of Sabra Healthcare REIT by 685.7% during the 3rd quarter. Farther Finance Advisors LLC now owns 3,952 shares of the real estate investment trust’s stock worth $74,000 after acquiring an additional 3,449 shares in the last quarter. Finally, Hantz Financial Services Inc. increased its holdings in shares of Sabra Healthcare REIT by 209.1% during the 3rd quarter. Hantz Financial Services Inc. now owns 3,956 shares of the real estate investment trust’s stock valued at $74,000 after acquiring an additional 2,676 shares during the last quarter. 99.40% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on SBRA shares. Scotiabank raised their price objective on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “sector perform” rating in a research note on Monday, March 2nd. Wells Fargo & Company upped their target price on Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 25th. Citizens Jmp increased their price target on Sabra Healthcare REIT from $22.00 to $23.00 and gave the company a “market outperform” rating in a report on Wednesday, February 18th. Truist Financial lifted their price target on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “hold” rating in a research report on Friday. Finally, Citigroup boosted their price objective on shares of Sabra Healthcare REIT from $21.00 to $24.00 and gave the stock a “buy” rating in a research note on Wednesday, February 18th. Five equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat, Sabra Healthcare REIT presently has an average rating of “Moderate Buy” and an average target price of $21.90.

Sabra Healthcare REIT Trading Down 0.8%

Sabra Healthcare REIT stock opened at $20.62 on Monday. Sabra Healthcare REIT, Inc. has a 52 week low of $15.75 and a 52 week high of $21.07. The company has a debt-to-equity ratio of 0.90, a quick ratio of 4.29 and a current ratio of 4.29. The firm has a market capitalization of $5.20 billion, a PE ratio of 32.22, a PEG ratio of 1.66 and a beta of 0.64. The business’s 50-day simple moving average is $19.65 and its 200-day simple moving average is $19.01.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its earnings results on Thursday, February 12th. The real estate investment trust reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.37 by ($0.26). The business had revenue of $201.35 million for the quarter, compared to the consensus estimate of $201.97 million. Sabra Healthcare REIT had a net margin of 20.09% and a return on equity of 5.63%. Sabra Healthcare REIT’s revenue for the quarter was up 16.2% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.36 EPS. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Equities research analysts forecast that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current year.

Sabra Healthcare REIT Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, February 27th. Stockholders of record on Friday, February 13th were paid a $0.30 dividend. The ex-dividend date was Friday, February 13th. This represents a $1.20 annualized dividend and a dividend yield of 5.8%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is presently 187.50%.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.